ENTITY
GC Biopharma Corp

GC Biopharma Corp (006280 KS)

115
Analysis
Health Care • South Korea
GC Biopharma is a biopharmaceutical company headquartered in Yongin, South Korea. It manufactures household medical drugs. The Company's product includes medicines for cold and fever, nutrition, antiseptic drug, and a lip balm.
more
bullish•Yuhan Corp
•21 Dec 2016 15:45

20 Million Chickens (And Ducks) Culled in Korea

It is estimated that more than 20 million chickens (and ducks) have been culled in Korea in the past several weeks, representing about 12% of all...

Logo
731 Views
Share
bullish•SillaJen Inc
•29 Nov 2016 05:36

SillaJen IPO Part 5 - Revenue & Valuation Estimates with Pexa-Vec's First Commercialization Year

We need to examine the size of SillaJen's expected sales in 2020, which is the reference year for its entire valuation. With an assumption that...

Logo
498 Views
Share
bullish•SillaJen Inc
•26 Nov 2016 03:48

SillaJen IPO Part 4 - IPO Price & Post-IPO Risks

SillaJen IPO price was set at ₩15,000, the lowest end of the indicative price band, after conducting the demand survey from (Nov 23-24) the...

Logo
460 Views
Share
bullish•SillaJen Inc
•21 Nov 2016 13:33

SillaJen IPO Part 3 - Competitive Strengths of Product (Pexa-Vec)

* In Part 3 (as below), I summarized the competitive strengths of product (Pexa-Vec).SillaJen's Pexa-Vec is an advanced liver cancer treatment...

Logo
390 Views
Share
bullish•SillaJen Inc
•03 Nov 2016 11:26

SillaJen IPO Part 2 - Growth Potential & Appropriate Valuation Level

* In Part 2 (as below), I summarized the growth potential and appropriate valuation level of SillaJen.Apparently, not many people are doubtful...

Logo
406 Views
Share
x